Mark Terrelonge, MD, MPH

HS Asst Clinical Professor
Neurology
+1 415 353-2273

Mark Terrelonge, MD is one of our core ZSFG outpatient physicians, and a member of the Neuromuscular Division at UCSF. He has a passion for understanding how people interact with and give back to the world. When patients come to his practice, they often have problems with their motion and movements and are passionate about getting better. The partnership between patients and physicians--in developing a treatment plan to improve the way in which the patient can interact with the world and better understand their disorder--motivates Dr. Terrelonge. 

Dr. Terrelonge is looking forward to opening a clinic at ZSFG for neuromuscular care, and to expanding neuromuscular and ALS clinics and telehealth to reach patients as far away as central California, and even to Alaska. These new clinics and telemedicine opportunities will improve equity of access for patients with neurologic disease, making world-class care available to all, regardless of their location or their ability to travel long distances for care. He sees a future in which community health partnerships expand access to excellent healthcare to all, beyond the walls of the tertiary care center.

Dr. Terrelonge is also passionate about serving as a role model for young prospective physicians, and to showing UCSF's commitment to diversity to our patients. It is through a demonstrated commitment to diversity in our physician providers, in our work in mentorship, and through work toward health equity--that we are delivering true change in the civil rights moment that we are living in right now.

Publications: 

Needs assessment for direct ophthalmoscopy training in neurology residency.

BMC medical education

Saroya J, Chahal N, Jiang A, Pet D, Rasool N, Terrelonge M, Yung M

Detection of High-Risk Paraneoplastic Antibodies Against TRIM9 and TRIM67 proteins.

Annals of neurology

Bartley CM, Ngo TT, Do LD, Zekeridou A, Dandekar R, Muñiz-Castrillo S, Alvarenga BD, Zorn KC, Tubati A, Pinto AL, Browne WD, Hullett PW, Terrelonge M, Schubert RD, Piquet AL, Binxia Y, Montalvo Perero MJ, Kung AF, Mann SA, Shah MP, Geschwind MD, Gelfand JM, DeRisi JL, Pittock SJ, Honnorat J, Pleasure SJ, Wilson MR

ALSUntangled #65: glucocorticoid corticosteroids.

Amyotrophic lateral sclerosis & frontotemporal degeneration

Goslinga JA, Terrelonge M, Bedlack R, Barkhaus P, Barnes B, Bertorini T, Bromberg M, Carter G, Chen A, Crayle J, Dimachkie M, Jiang L, Levitsky G, Lund I, Martin S, Mcdermott C, Pattee G, Pierce K, Ratner D, Slachtova L, Sun Y, Wicks P

Common Focal Neuropathies in the Hospitalized Patient.

Neurologic clinics

Terrelonge M, Rosow L

KIBRA, MTNR1B, and FKBP5 genotypes are associated with decreased odds of incident delirium in elderly post-surgical patients.

Scientific reports

Terrelonge M, LaHue SC, Tang C, Movsesyan I, Pullinger CR, Dubal DB, Leung J, Douglas VC

ALSUntangled #63: ketogenic diets.

Amyotrophic lateral sclerosis & frontotemporal degeneration

Bedlack R, Barkhaus PE, Barnes B, Beauchamp M, Bertorini T, Bromberg MB, Carter GT, Chaudry V, Cudkowicz M, Jackson C, Levitsky G, Lund I, McDermott C, Novella S, Olby N, Ostrow L, Pattee GL, Heiman-Patterson T, Ratner D, Salmon K, Steves S, Terrelonge M, Wicks P, Wills AM

Outcomes Following Implementation of a Hospital-Wide, Multicomponent Delirium Care Pathway.

Journal of hospital medicine

LaHue SC, Maselli J, Rogers S, Casatta J, Chao J, Croci R, Gonzales R, Holt B, Josephson SA, Lama S, Lau C, McCulloch C, Newman JC, Terrelonge M, Yeager J, Douglas VC

CSF ß-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease.

Journal of molecular neuroscience : MN

Terrelonge M, Marder KS, Weintraub D, Alcalay RN